Applied DNA Sciences (APDN, Financial) has announced a 1-for-15 reverse stock split for its common stock. This change will take effect at 12:01 a.m. Eastern Time on June 2, 2025. From market open that same day, APDN shares will trade on a split-adjusted basis on The Nasdaq Capital Market. Despite the adjustment, the ticker symbol "APDN" will remain unchanged. However, the stock will adopt a new CUSIP number: 03815U607, while the CUSIP number for the company’s book entry warrants will stay the same.
Post-split, the outstanding common shares will decrease significantly from about 7.8 million to around 519 thousand. The authorized number of shares will remain unchanged. Adjustments will also be made to shares issuable under the company's stock options, restricted stock units, warrants, and equity incentive plans to align with the split. Fractional shares will not be issued; instead, they will be rounded up to the nearest whole share. The par value of each common share will remain at $0.001.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 1 analysts, the average target price for Applied DNA Sciences Inc (APDN, Financial) is $1.50 with a high estimate of $1.50 and a low estimate of $1.50. The average target implies an upside of 190.08% from the current price of $0.52. More detailed estimate data can be found on the Applied DNA Sciences Inc (APDN) Forecast page.
Based on the consensus recommendation from 1 brokerage firms, Applied DNA Sciences Inc's (APDN, Financial) average brokerage recommendation is currently 3.0, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Applied DNA Sciences Inc (APDN, Financial) in one year is $2.16, suggesting a upside of 317.71% from the current price of $0.5171. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Applied DNA Sciences Inc (APDN) Summary page.
